|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
10.62(B) |
Last
Volume: |
615,229 |
Avg
Vol: |
474,972 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1272 |
Guru Rank Value : -4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
6,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,248,939 |
$2,162,353 |
Total People Bought |
0 |
0 |
2 |
3 |
Total Buy Transactions |
0 |
0 |
2 |
5 |
Total Shares Sold |
26,780 |
28,416 |
68,842 |
119,413 |
Total Sell Value |
$6,604,861 |
$6,979,055 |
$16,175,390 |
$28,218,514 |
Total People Sold |
2 |
3 |
7 |
8 |
Total Sell Transactions |
2 |
4 |
15 |
29 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wallman Richard F |
Director |
|
2024-05-13 |
4 |
A |
$228.41 |
$232,750 |
D/D |
1,019 |
23,547 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2024-05-10 |
4 |
S |
$226.97 |
$295,969 |
D/D |
(1,304) |
23,276 |
|
10% |
|
Pease Flavia |
Corporate Executive VP & CFO |
|
2024-05-02 |
4 |
D |
$232.69 |
$207,792 |
D/D |
(893) |
8,007 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-03-08 |
4/A |
S |
$267.52 |
$216,156 |
D/D |
(808) |
7,825 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-03-08 |
4/A |
OE |
$267.52 |
$216,156 |
D/D |
808 |
8,633 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-03-08 |
4 |
S |
$267.52 |
$216,156 |
D/D |
(808) |
7,024 |
|
18% |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-03-04 |
4 |
S |
$260.88 |
$717,890 |
D/D |
(2,750) |
7,832 |
|
16% |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-03-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
412 |
26,554 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-02-29 |
4 |
S |
$253.43 |
$959,545 |
D/D |
(3,786) |
7,132 |
|
17% |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2024-02-29 |
4 |
S |
$253.70 |
$1,268,500 |
D/D |
(5,000) |
13,550 |
|
17% |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2024-02-22 |
4 |
S |
$248.50 |
$1,006,425 |
I/I |
(4,050) |
22,879 |
|
18% |
|
Foster James C |
Chairman, President and CEO |
|
2024-02-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
224,613 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2024-02-15 |
4 |
S |
$238.93 |
$200,223 |
D/D |
(838) |
24,620 |
|
16% |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-02-15 |
4 |
OE |
$144.67 |
$850,949 |
D/D |
5,882 |
8,478 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-02-15 |
4 |
AS |
$237.20 |
$1,418,767 |
D/D |
(5,882) |
2,596 |
|
-16% |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2024-02-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
424 |
47,691 |
|
- |
|
Kemps-Polanco Reshema |
Director |
|
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
170 |
170 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-01-29 |
4/A |
D |
$220.28 |
$117,850 |
D/D |
(535) |
8,387 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2024-01-29 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,070 |
8,922 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2024-01-29 |
4/A |
D |
$220.28 |
$163,888 |
D/D |
(744) |
11,293 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2024-01-29 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,934 |
12,037 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2024-01-29 |
4/A |
D |
$220.28 |
$2,321,751 |
D/D |
(10,540) |
228,318 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2024-01-29 |
4/A |
A |
$0.00 |
$0 |
D/D |
23,741 |
238,858 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-01-29 |
4/A |
D |
$220.28 |
$68,948 |
D/D |
(313) |
10,575 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2024-01-29 |
4/A |
A |
$0.00 |
$0 |
D/D |
948 |
10,888 |
|
- |
|
1200 Records found
|
|
Page 3 of 48 |
|
|